PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Wednesday reported a loss of $45.1 million in its third quarter.
On a per-share basis, the Pasadena, California-based company said it had a loss of 71 cents.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $10.7 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $7.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR
